OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Vivreon Biosciences, LLC

1 Projects | 1 Researchers | $150,000 Invested

2015

Vivreon Biosciences, LLC

Milton Greenberg, PhD

Lead Optimization and Pre-Clinical Development of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease

  • Funding Amount: $150,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Calcium Regulation
  • Status: Closed